Ro (@ro) header
Ro (@ro) profile picture

Ro

@ro

Building a patient-centric healthcare system.

 New York, NY
ro.co/lp/sparks/nightcap
Joined September 2018
  • Tweets957
  • Following348
  • Followers19.2K
311Media
Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)Photo by Ro (@ro)
Refounding Ro to $3B+ Run Rate

Refounding Ro to $3B+ Run Rate

Article · @ZReitano
98
56
81
542
214,436
Introducing Ro Research Lab

Introducing Ro Research Lab

Article · @ZReitano
5
10
8
41
7,792
Introducing Robin AI

Introducing Robin AI

Article · @ZReitano
16
18
11
114
43,816
The Economics of a Super Bowl Ad

The Economics of a Super Bowl Ad

Article · @ZReitano
94
218
103
1,887
1,499,519
.@Ro has launched a new GLP-1 pill in partnership with Novo Nordisk. CEO @ZReitano on how the pill will "usher in a new era of digital health": "It's the first time a drug of this size and scale launches nationwide on Ro, so someone can see an ad and go from diagnosis to delivery in 48 hours or less."
1
3
12
10,512
Novo Nordisk's Wegovy pill is launching direct-to-consumer with @ro CEO @ZReitano breaks down what the launch means for patients, his company's partnership with $NVO, and more cnb.cx/4aSUKJP
Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill

Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill

Ro Co-Founder and CEO Zach Reitano joins 'Fast Money' to talk the launch of Wegovy's oral GLP-1 offering, demand for the pill, and its partnership with Novo Nordisk to distribute the medication.

cnbc.com
2
12
1
28
14,063
Can ‘food noise’ be measured? Telehealth giant Ro rolls out a new scale for obesity care trib.al/02YYtOf
Can ‘food noise’ be measured? Telehealth giant Ro rolls out a new scale for obesity care

Can ‘food noise’ be measured? Telehealth giant Ro rolls out a new scale for obesity care

Can "food noise" be measured? Telehealth giant Ro is rolling out a new scale for obesity care.

statnews.com
3
8
13,252
Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview. today.com/health/womens-heal…
EXCLUSIVE: Serena Williams Says GLP-1 Medication Helped Her Lose 31 Pounds

EXCLUSIVE: Serena Williams Says GLP-1 Medication Helped Her Lose 31 Pounds

The tennis legend says she needed extra medical support after giving birth to her second daughter.

today.com
11
35
123
86
247,875
Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy® for $199 plus their first month of the Ro Body membership for just $45.
Image from Z Reitano (@ZReitano)
3
8
2
33
32,248
Some *BIG* news from the team @ro today — we're thrilled to announce a new partnership with the one and only Charles Barkley! 🏀 As we got to know Charles through this process, it became clear how personally meaningful this subject is to him — even beyond his own weight loss journey. Charles has seen firsthand how powerful GLP-1 therapies can be as a tool for improving health, and he’s passionate about increasing awareness and access to these treatments, especially in underserved communities. We're proud to support Charles on his own health journey and to share his story — along with his signature humor and candor — through this partnership. Huge thanks to the many talented colleagues and partners involved in bring this incredible collaboration to life. We’re just getting started!
Image from Will Flaherty (@flahertyiv)
4
3
2
30
27,164
A new deal between @Ro and $NVO allows patients to get its flagship weight loss drug Wegovy for as low as $499 per month CEO @ZReitano breaks down the details of the deal and what it means for patients cnb.cx/4jvFofs
Ro CEO digs into new Wegovy cash pay offering

Ro CEO digs into new Wegovy cash pay offering

Zach Reitano, Ro, joins 'Fast Money' to talk cheaper Wegovy options.

cnbc.com
3
11
23
26,492
Today, @ro is announcing a collaboration with @novonordisk — starting with an integration with NovoCare® Pharmacy. Fighting for patients means making it as easy and affordable as possible to access high-quality treatment, and that’s what Ro and Novo aim to do.
4
3
2
36
29,583
$LLY lowering the price of the vials! $349 for 2.5 and $499 for higher doses on monthly orders. Big win for patients! Also… they’re in stock (always have been since launch). Proud to offer seamless access via @Ro in unique integration with @EliLillyandCo
8
6
3
33
64,338
1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. endpts.com/ros-weight-loss-b… ➡️ Avg weight loss: 15.8% after 12 months on GLP-1s ➡️ 80% of patients with metabolic risks improved their lab results
Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program...

Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program...

With direct-to-patient services for obesity drugs facing scrutiny, the telehealth startup Ro is trying to prove that its online weight loss program is up to snuff. To that end, the startup released...

endpoints.news
6
8
44
54,027
Replying to @axios @WashSpirit @sarafischer
Catch @Ro CEO @ZReitano at in conversation with @danprimack at #AxiosBFD in New York. Tune in tomorrow at 2:50pm ET
Image from Axios (@axios)
1
4
10
44,432
Checking GLP-1 drug insurance coverage just got a little easier, thanks to a new tool from @ro. CEO @ZReitano explains how it works. He also gives his read on the blockbuster obesity drug market.
3
7
4
28
57,428
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs cnbc.com/2024/08/13/ro-launc…
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Ro said it hopes its new tool will be able to help patients understand their GLP-1 coverage options so they can decide how to pursue weight loss.

cnbc.com
7
26
30,974
GLP-1 drugs are in short supply, but a new supply tracker could help patients find what they need @Ro CEO and Co-Founder @ZReitano breaks down his company's newest tracker and how producers like $LLY and $NVO are handling supply and distribution obstacles:
5
18
1
54
36,442
"We are dramatically underestimating the demand," Ro CEO Zach Reitano says on GLP-1 drugs. "I think we're going to see that demand/supply mismatch for years."
2
7
2
21
26,741
What motivates people to lose weight? This is an important topic. At @Ro, we’re constantly speaking to our patients to understand their goals and their reasons for joining our Body Program. Check out some of that data and what it says about men and women’s motivations for seeking treatment with GLP-1s (hint: they're more similar than you might think) ro.co/research/men-and-women…
2
2
3
23
17,788
Load more